Mahalpure, S., Mahalpure, G.S., Daga, V. and Nehete, H. 2026. A Review on Resmetirom: An Oral Thyroid Hormone Receptor-β Agonist for the Treatment of Metabolically dysfunction-Associated Steatohepatitis (MASH). Journal of Pharmaceutical and Biopharmaceutical Research. 8, 1 (Jul. 2026), 551-568. DOI:https://doi.org/10.25082/JPBR.2026.01.002.